| Customization: | Available |
|---|---|
| CAS No.: | 352-97-6 |
| Formula: | N/a |
|
Still deciding? Get samples of US$ 50/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Glycocyamine, with the CAS number 352-97-6, is an organic compound that is classified as an alpha amino acid derivative. It is also known by several synonyms including Guanidinoacetic Acid, Guanyl Glycine, N-Guanylglycine, and others. This white crystalline powder has a molecular formula of C3H7N3O2, a molecular weight of 117.11 g/mol, and a melting point that exceeds 300°C. It is soluble in water and ethanol but insoluble in chloroform.
Glycocyamine plays a crucial role in the biosynthesis of creatine, a high-energy compound found in muscles, and is involved in energy metabolism. It is used as a dietary supplement to enhance athletic performance, improve muscle strength, and increase energy levels. The compound is also used in the production of creatine supplements and can be found in meats and fish, but is also available in supplement form.
In its production, glycocyamine can be manufactured through the reaction of cyanamide with glycine in the presence of sodium hydroxide, followed by purification steps such as crystallization and recrystallization. It is typically packaged in airtight containers to prevent moisture and contamination and is transported in compliance with regulations for hazardous materials.
The compound has been noted for its potential effects on the body, including the stimulation of insuli secretion and the savings of arginine in animal nutrition. It is also considered a powerful antibiotic due to its role in the synthesis of glutathione, an important antioxidant in the body. However, it is important to handle glycocyamine with care due to its potential to cause skin and eye irritation, and it is classified with certain hazard codes and safety statements to guide its safe use. Chronic exposure to guanidinoacetic acid, such as that which occurs in uremic syndrome, may require treatment such as kidney dialysis to alleviate symptoms
){kind=link}